Will Journavx, a New, Non-Addictive Painkiller, Eliminate Opioid Addiction?
The FDA has approved suzetrigine, a non-opiate signal blocker, for treatment of moderate and severe acute pain.
Latest developments in causes and treatments
The FDA has approved suzetrigine, a non-opiate signal blocker, for treatment of moderate and severe acute pain.